The amplification and overexpression of MDM2 are present in human malignant gliomas and cell lines, independent of p53 status [36, 37], and high MDM2 expression is correlated with poor prognosis of glioma patients [38]. The gene discussed is MDM2; the disease is central nervous system cancer.